Clinical Trials
92 trialsItraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus
National Cancer Institute (NCI)
IMMULAB - Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC)
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Assess the Efficacy of Pembrolizumab Plus Radiotherapy or Ablation in Metastatic Colorectal Cancer Patients
Memorial Sloan Kettering Cancer Center
HARMONI
Hospices Civils de Lyon
ORCHESTRA
Radboud University Medical Center
LICoRN-01
Assistance Publique - Hôpitaux de Paris
CARP
University of Leipzig
ISCOLIM
University of Aarhus
SM-OCT-01
Seoul National University Hospital
The Role and Safety of Radiofrequency Ablation in Recurrent Liver Metastasis of Colorectal Cancer
Peking University Cancer Hospital & Institute
RFA Versus SBRT for Recurrent Small HCC
Sun Yat-sen University
EXPECT
Tenwek Hospital
Healing of the Esophageal Mucosa After RFA of Barrett's Esophagus
Dallas VA Medical Center
Cytokine Change in Hepatocellular Carcinoma Treated by Thermal Ablation
Chinese University of Hong Kong
Stereotactic Body Radiotherapy Versus Radiofrequency Ablation for Unresectable, Small (≤ 3 cm) HCC
Asan Medical Center
Spyglass+RFA Versus Cytobrush+RFA for Extrahepatic Cholangiocarcinoma
First People's Hospital of Hangzhou
Sorafenib Therapy Prior to Radiofrequency Ablation for Intermediate Sized Hepatocellular Cancer
Beth Israel Deaconess Medical Center
ERFA-PNET
Oslo University Hospital
A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC)
National Institutes of Health Clinical Center (CC)
RFA to Prevent Metachronous Squamous Neoplasia Recurrence After Complete Endoscopic Submucosal Dissection
E-DA Hospital
RFA Combined With Chemotherapy for Unresectable Cholangiocarcinoma
First People's Hospital of Hangzhou
COLLISION
Amsterdam UMC, location VUmc
Anatomical Radiofrequency Ablation for Small Hepatocellular Carcinoma
Seoul National University Hospital
Phase II Study of Regorafenib and Toripalimab Combined With RFA in Patients With CRCLM
Sun Yat-sen University
Laparoscopic Hepatectomy and Radiofrequency Ablation in the Treatment of Early Hepatocellular Carcinoma
Southwest Hospital, China
ILOC
European Organisation for Research and Treatment of Cancer - EORTC
Effectiveness of Microwave Ablation of Hepatocellular Carcinoma as Compared to Radiofrequency Ablation
Chinese University of Hong Kong
Radiofrequency Ablation Combined With Toripalimab and Lenvatinib in the Treatment of Short-term Recurrent Hepatocellular Carcinoma.
Henan Cancer Hospital
HR-HCC/PHT
Guangxi Medical University
Radiofrequency Ablation Plus Radiotherapy for Small Hepatocellular Carcinoma
Guangxi Medical University
Comparison of Treatments for Barrett's Esophagus With High-Grade Dysplasia/Early Adenocarcinoma
Massachusetts General Hospital
Clinical Effect and Safety of PDT and RFA for Unresectable EHCC
First People's Hospital of Hangzhou
BURN
Erbe Elektromedizin GmbH
RFA
Taipei Medical University WanFang Hospital
RFA vs. SBRT for Small HCC
Sun Yat-sen University
Endoscopic Biliary Co-axial Stent Placement Plus/Minus Use of Radiofrequency Ablation (RFA) for Clearance of Occluded Self Expandable Metal Stents (SEMS) in Patients With Distal Biliary Obstruction From Unresectable Biliary-pancreatic Malignancies
Memorial Sloan Kettering Cancer Center
Endobiliary RFA for Unresectable Malignant Biliary Strictures
Eastern Hepatobiliary Surgery Hospital
ACRIN-6673
American College of Radiology Imaging Network
REACH
Medtronic - MITG
ARTC-HCC
Guangxi Medical University
RFA Plus Carrizumab vs Carrizumab Alone for HCC
Second Affiliated Hospital, School of Medicine, Zhejiang University
SAIL
Sun Yat-sen University
Radiofrequency Ablation for Patients With Esophageal Squamous Cell Neoplasia
Medtronic - MITG
ARMTICH
Assistance Publique - Hôpitaux de Paris
Camrelizumab Combined With Apatinib 、XELOX 、RFA in the Treatment of Liver Metastases of Colorectal Cancer
Zhongshan Hospital Xiamen University
Radiofrequency Ablation vs Sham Procedure for Symptomatic Cervical Inlet Patch
Guy's and St Thomas' NHS Foundation Trust
Combined Radiotherapy and Radiofrequency Ablation for Hepatocellular Carcinoma
Guangxi Medical University
Tremelimumab With Chemoembolization or Ablation for Liver Cancer
National Institutes of Health Clinical Center (CC)
Endobiliary Radiofrequency Ablation With S-1 for Unresectable Cholangiocarcinoma
First People's Hospital of Hangzhou
QPEAvsRFA
Sun Yat-sen University